TCIM
CORZ icon

TOMS Capital Investment Management’s Core Scientific CORZ Stock Holding History

TOMS Capital Investment Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,663,000
Closed -$98.7M – 24
2025
Q3 		$102M Buy
+5,663,000
New +$83.1M 2.36% 10

Other funds holding CORZ

SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

TOMS Capital Investment Management's CORZ Position: Q4 2025 in Review

TOMS Capital Investment Management sold out of Core Scientific (CORZ) in Q4 2025, closing a stake of 5,663,000 shares — an estimated $98.7M sold.

TOMS Capital Investment Management first reported a position in CORZ in Q3 2025 and held it in 1 quarter. The position peaked at $102M in Q3 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • TOMS Capital Investment Management reported no remaining Core Scientific position as of Q4 2025 after selling out during the quarter.
  • TOMS Capital Investment Management sold 5,663,000 Core Scientific shares in Q4 2025, an estimated $98.7M.
  • TOMS Capital Investment Management first reported a position in Core Scientific in Q3 2025 and held it in 1 quarter.
  • TOMS Capital Investment Management's Core Scientific position peaked at $102M in Q3 2025.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on TOMS Capital Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.